US 11,511,762
Application 16/682,644 · Granted Nov 29, 2022
Redundancy system and method
Estimated expiration
April 3, 2040
13y 137d remaining
Earliest effective filing
Nov 13, 2019
+ 20 years
Nov 13, 2039
PTA +142d
Apr 3, 2040
No TD
—
Final
Apr 3, 2040
- Earliest effective filing
- Nov 13, 2019
- + 20 years
- Nov 13, 2039
- PTA +142d
- Apr 3, 2040
- No TD
- —
- Final
- Apr 3, 2040
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- November 13, 2019
- Earliest effective filing
- November 13, 2019
- Issue date
- November 29, 2022
- PTA
- +142 days
- Base expiry (before PTA)
- November 13, 2039
November 13, 2019 + 20 years = November 13, 2039 + 142 PTA days = April 3, 2040
- PRO62/760,575 — Provisional — not used for base term
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
You have the date. Your AI can have the file.
Application 16/682,644 · US 11,511,762
PatentReply compiles the prosecution history behind US 11,511,762: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new published application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US11511762Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.